PHL-TOPIRAMATE DIN 02271184
Health Canada record
| Active ingredient(s) | TOPIRAMATE 25 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N03AX11 TOPIRAMATE |
| Original market date | 11-Oct-2005 |
| Current status date | 11-Oct-2005 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pharmel Inc. — licence 101409, not currently licensed, last inspection rating C (2018-01-15).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TOPIRAMATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02279614 | APO-TOPIRAMATE | APOTEX INC | Tablet | TOPIRAMATE 25 MG | Marketed |
| 02279622 | APO-TOPIRAMATE | APOTEX INC | Tablet | TOPIRAMATE 50 MG | Approved |
| 02279630 | APO-TOPIRAMATE | APOTEX INC | Tablet | TOPIRAMATE 100 MG | Marketed |
| 02279649 | APO-TOPIRAMATE | APOTEX INC | Tablet | TOPIRAMATE 200 MG | Marketed |
| 02345811 | AURO-TOPIRAMATE | AURO PHARMA INC | Tablet | TOPIRAMATE 50 MG | Approved |
| 02345803 | AURO-TOPIRAMATE | AURO PHARMA INC | Tablet | TOPIRAMATE 25 MG | Marketed |
| 02287773 | GLN-TOPIRAMATE | GLENMARK PHARMACEUTICALS CANADA INC. | Tablet | TOPIRAMATE 100 MG | Marketed |
| 02287781 | GLN-TOPIRAMATE | GLENMARK PHARMACEUTICALS CANADA INC. | Tablet | TOPIRAMATE 200 MG | Marketed |
| 02287765 | GLN-TOPIRAMATE | GLENMARK PHARMACEUTICALS CANADA INC. | Tablet | TOPIRAMATE 25 MG | Marketed |
| 02345269 | JAMP TOPIRAMATE TABLETS | JAMP PHARMA CORPORATION | Tablet | TOPIRAMATE 100 MG | Marketed |
| 02345250 | JAMP TOPIRAMATE TABLETS | JAMP PHARMA CORPORATION | Tablet | TOPIRAMATE 25 MG | Marketed |
| 02345277 | JAMP TOPIRAMATE TABLETS | JAMP PHARMA CORPORATION | Tablet | TOPIRAMATE 200 MG | Marketed |
| 02315645 | MINT-TOPIRAMATE | MINT PHARMACEUTICALS INC | Tablet | TOPIRAMATE 25 MG | Marketed |
| 02315661 | MINT-TOPIRAMATE | MINT PHARMACEUTICALS INC | Tablet | TOPIRAMATE 200 MG | Marketed |
| 02315653 | MINT-TOPIRAMATE | MINT PHARMACEUTICALS INC | Tablet | TOPIRAMATE 100 MG | Marketed |
| 02263351 | MYLAN-TOPIRAMATE | MYLAN PHARMACEUTICALS ULC | Tablet | TOPIRAMATE 25 MG | Marketed |
| 02263378 | MYLAN-TOPIRAMATE | MYLAN PHARMACEUTICALS ULC | Tablet | TOPIRAMATE 100 MG | Marketed |
| 02263386 | MYLAN-TOPIRAMATE | MYLAN PHARMACEUTICALS ULC | Tablet | TOPIRAMATE 200 MG | Marketed |
| 02312085 | PMS-TOPIRAMATE | PHARMASCIENCE INC | Tablet | TOPIRAMATE 50 MG | Marketed |
| 02263017 | PMS-TOPIRAMATE | PHARMASCIENCE INC | Tablet | TOPIRAMATE 200 MG | Marketed |
| 02262991 | PMS-TOPIRAMATE | PHARMASCIENCE INC | Tablet | TOPIRAMATE 25 MG | Marketed |
| 02263009 | PMS-TOPIRAMATE | PHARMASCIENCE INC | Tablet | TOPIRAMATE 100 MG | Marketed |
| 02313669 | PRO-TOPIRAMATE | PRO DOC LIMITEE | Tablet | TOPIRAMATE 100 MG | Marketed |
| 02313650 | PRO-TOPIRAMATE | PRO DOC LIMITEE | Tablet | TOPIRAMATE 25 MG | Marketed |
| 02313677 | PRO-TOPIRAMATE | PRO DOC LIMITEE | Tablet | TOPIRAMATE 200 MG | Marketed |
| 02248862 | TEVA-TOPIRAMATE | TEVA CANADA LIMITED | Tablet | TOPIRAMATE 200 MG | Marketed |
| 02248860 | TEVA-TOPIRAMATE | TEVA CANADA LIMITED | Tablet | TOPIRAMATE 25 MG | Marketed |
| 02248861 | TEVA-TOPIRAMATE | TEVA CANADA LIMITED | Tablet | TOPIRAMATE 100 MG | Marketed |
| 02239907 | TOPAMAX | JANSSEN INC | Capsule | TOPIRAMATE 15 MG | Marketed |
| 02239908 | TOPAMAX | JANSSEN INC | Capsule | TOPIRAMATE 25 MG | Marketed |
| 02271176 | DOM-TOPIRAMATE | DOMINION PHARMACAL | Tablet | TOPIRAMATE 200 MG | Cancelled Post Market |
| 02271141 | DOM-TOPIRAMATE | DOMINION PHARMACAL | Tablet | TOPIRAMATE 25 MG | Cancelled Post Market |
| 02271168 | DOM-TOPIRAMATE | DOMINION PHARMACAL | Tablet | TOPIRAMATE 100 MG | Cancelled Post Market |
| 02334356 | NU-TOPIRAMATE | NU-PHARM INC | Tablet | TOPIRAMATE 200 MG | Cancelled (Unreturned Annual) |
| 02334348 | NU-TOPIRAMATE | NU-PHARM INC | Tablet | TOPIRAMATE 100 MG | Cancelled (Unreturned Annual) |
| 02334321 | NU-TOPIRAMATE | NU-PHARM INC | Tablet | TOPIRAMATE 50 MG | Cancelled (Unreturned Annual) |
| 02334313 | NU-TOPIRAMATE | NU-PHARM INC | Tablet | TOPIRAMATE 25 MG | Cancelled (Unreturned Annual) |
| 02271206 | PHL-TOPIRAMATE | PHARMEL INC | Tablet | TOPIRAMATE 200 MG | Cancelled Post Market |
| 02271192 | PHL-TOPIRAMATE | PHARMEL INC | Tablet | TOPIRAMATE 100 MG | Cancelled Post Market |
| 02256835 | RATIO-TOPIRAMATE | TEVA CANADA LIMITED | Tablet | TOPIRAMATE 100 MG | Cancelled Post Market |
| 02256843 | RATIO-TOPIRAMATE | TEVA CANADA LIMITED | Tablet | TOPIRAMATE 200 MG | Cancelled Post Market |
| 02256827 | RATIO-TOPIRAMATE | TEVA CANADA LIMITED | Tablet | TOPIRAMATE 25 MG | Cancelled Post Market |
| 02260050 | SANDOZ TOPIRAMATE | SANDOZ CANADA INCORPORATED | Tablet | TOPIRAMATE 25 MG | Cancelled Post Market |
| 02267837 | SANDOZ TOPIRAMATE | SANDOZ CANADA INCORPORATED | Tablet | TOPIRAMATE 200 MG | Cancelled Post Market |
| 02260069 | SANDOZ TOPIRAMATE | SANDOZ CANADA INCORPORATED | Tablet | TOPIRAMATE 100 MG | Cancelled Post Market |
| 02231385 | TOPAMAX | JANSSEN INC | Tablet | TOPIRAMATE 50 MG | Cancelled Pre Market |
| 02231386 | TOPAMAX | JANSSEN INC | Tablet | TOPIRAMATE 300 MG | Cancelled Pre Market |
| 02231387 | TOPAMAX | JANSSEN INC | Tablet | TOPIRAMATE 400 MG | Cancelled Pre Market |
| 02230894 | TOPAMAX 100MG | JANSSEN INC | Tablet | TOPIRAMATE 100 MG | Cancelled Post Market |
| 02230896 | TOPAMAX 200MG | JANSSEN INC | Tablet | TOPIRAMATE 200 MG | Cancelled Post Market |
| 02230893 | TOPAMAX 25MG | JANSSEN INC | Tablet | TOPIRAMATE 25 MG | Cancelled Post Market |
| 02344874 | TOPIRAMATE | COBALT PHARMACEUTICALS COMPANY | Tablet | TOPIRAMATE 200 MG | Cancelled Pre Market |
| 02344858 | TOPIRAMATE | COBALT PHARMACEUTICALS COMPANY | Tablet | TOPIRAMATE 25 MG | Cancelled Pre Market |
| 02344866 | TOPIRAMATE | COBALT PHARMACEUTICALS COMPANY | Tablet | TOPIRAMATE 100 MG | Cancelled Pre Market |
| 02345412 | TOPIRAMATE | MELIAPHARM INC | Tablet | TOPIRAMATE 25 MG | Cancelled Post Market |
| 02345439 | TOPIRAMATE | MELIAPHARM INC | Tablet | TOPIRAMATE 100 MG | Cancelled Post Market |
| 02345447 | TOPIRAMATE | MELIAPHARM INC | Tablet | TOPIRAMATE 200 MG | Cancelled Post Market |
| 02325136 | ZYM-TOPIRAMATE | ZYMCAN PHARMACEUTICALS INC | Tablet | TOPIRAMATE 25 MG | Cancelled Post Market |
| 02325144 | ZYM-TOPIRAMATE | ZYMCAN PHARMACEUTICALS INC | Tablet | TOPIRAMATE 100 MG | Cancelled Post Market |
| 02325152 | ZYM-TOPIRAMATE | ZYMCAN PHARMACEUTICALS INC | Tablet | TOPIRAMATE 200 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 7361 | 2005-09-14 | Abbreviated New Drug Submission (ANDS) | NEW MANUFACTURER AND PRODUCT NAME |
International API supply for TOPIRAMATE
4 valid EDQM Certificates of Suitability from 4 holders. 20 active FDA Drug Master Files.
Request a quote for PHL-TOPIRAMATE